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Abstract 
Objective: Apathy is a prominent syndrome across neurodegenerative diseases. The 
Dimensional Apathy Scale (DAS) assesses three apathy subtypes, Executive, Emotional, 
Initiation and is sensitive and valid in amyotrophic lateral sclerosis (ALS), Alzheimer’s 
Disease (AD) and Parkinson’s Disease. This study describes the development of the brief 
DAS (b-DAS), which will enable apathy to be swiftly detected in the clinic. Method: 102 
ALS and 102 AD patients’ previously collected data was used. Mokken analyses was 
performed on item-level data of each informant/carer-rated DAS subscale (Executive, 
Emotional and Initiation) for the initial scale reduction. Item-total correlational analyses 
against standard apathy (convergent validity criteria) and depression (divergent validity 
criteria) measures and qualitative examination of items aided final item selection. Receiver 
Operating Curve Analysis determined optimal cut-offs for the reduced subscales. Results: 
Mokken analyses suggested unidimensionality of each DAS subscale. Three items were 
removed that failed to satisfy monotone homogeneity model requirements, 3 items were 
removed due to validity criteria not being met and 6 items were removed due to a 
combination of lower item scalability and item-total correlations. Item-theme examination 
further reduced the b-DAS to 9 items, 3 per subscale, with a supplemental awareness deficit 
assessment being added. Sensitivity and specificity-based optimal cut-offs were calculated 
for each b-DAS subscale. Conclusions: The study presents the b-DAS, an informant/carer-
based robust yet short multidimensional apathy instrument with good convergent and 
divergent validity, with recommended clinical cut-offs. The b-DAS is appropriate for use in 
the clinic and for research to quickly and comprehensively screen for apathy subtype 
impairments. 
Keywords: apathy; assessment; short form; dementia; amyotrophic lateral sclerosis 
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Introduction 
Apathy is defined as a lack of motivation toward goal directed behavior (Marin, 1991) and 
has been shown to be prevalent in neurodegenerative and neuropsychiatric disease, such as 
dementia, amyotrophic lateral sclerosis (ALS), Parkinson’s Disease, traumatic brain injury 
and schizophrenia (Chase, 2011; Radakovic & Abrahams, 2018; Selbæk, Engedal & Bergh, 
2013; Strong et al., 2017). It can often manifest in cognitive, behavioural and emotional 
domains, for example through withdrawal, inertia, lack of initiative or avolition, blunting or 
reduction of emotions or asociality. Apathy has been shown to be associated with impaired 
activities of daily living, carer distress or burden, quality of life and survival in 
neurodegenerative disease (e.g. Starkstein et al., 2006; Kamiya et al., 2014; Watermeyer et 
al., 2015; Caga et al, 2016). 
 
It is now established that apathy is a multidimensional syndrome, composed of different 
subtypes of demotivation. These subtypes are thought to have distinct neural substrates and 
several models relating to neural circuitry have been proposed, particularly in relation to the 
prefrontal cortex-basal ganglia networks (e.g. Levy & Dubois, 2006; Levy, 2012). Apathy as 
a syndrome can be practically surmised through a Dimensional Apathy Framework 
(Radakovic & Abrahams, 2018), which is comprised of a triadic structure including 
Executive apathy, a lack of motivation for planning, attention or organisation, Emotional 
apathy, a lack of emotional motivation (indifference or emotional neutrality) and Initiation 
apathy, a lack of motivation for self-generation of thoughts or actions. These apathy subtypes 
are assessed using the Dimensional Apathy Scale (DAS; Radakovic, & Abrahams, 2014), 
which is a multidimensional apathy instrument that quantifies apathy subtypes independent of 
physical disability and so is particularly suitable for patients with motor disorders (Radakovic 
et al., 2016; Santangelo et al., 2017a; Santangelo et al., 2017b; Radakovic, Davenport, Starr 
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& Abrahams, 2018). It has been shown to differentiate apathy subtype profiles in different 
neurodegenerative diseases, with only Initiation apathy being characteristic of amyotrophic 
lateral sclerosis (ALS; Radakovic et al., 2016) and a combination of Executive and Initiation 
apathy being characteristic of Parkinson’s disease (Radakovic et al., 2018) both independent 
of physical disability. In terms of cognitive dysfunction, Initiation and Emotional apathy have 
been shown to associate with executive dysfunction and emotional recognition deficits in 
ALS (Radakovic et al., 2017b). In Parkinson’s disease, Executive apathy has been shown to 
associate with activities of daily living and quality of life (Radakovic et al., 2018; D'Iorio et 
al., 2017). Further, research in Alzheimer’s Disease (AD) seem to show a global apathy over 
all subtypes (Radakovic et al., 2017a). The Dimensional Apathy Framework recognizes 
insight or awareness as an integrated element to apathy presentation (Radakovic & 
Abrahams, 2018). In accord with other studies (Starkstein, 2014) insight or awareness can be 
assessed using specific assessment or self-informant/carer discrepancy scores. Further, the 
global apathy subtype profile observed in AD was found to be typified by distinctive deficits 
in awareness of apathy subtypes more localised to Executive and Initiation apathy 
(Radakovic et al., 2017a), with other research finding distinct apathy associated awareness 
deficits in Frontotemporal dementia (Fernández-Matarrubia et al., 2018). Therefore, the 
application of subtype assessment and this framework has furthered our understanding and 
efficacy in assessment of syndromic apathy. 
 
Clinicians are often constrained by time when administering assessments to patients and/or 
their carers, having to manage a variety of assessments to attain a more complete clinical 
picture. This calls for shorter yet comprehensive tools. With the importance of 
multidimensional apathy assessment being repeatedly reaffirmed (Levy, 2012; Costa et al., 
2017; Lanctôt et al., 2017), it would therefore be advantageous both in research and clinically 
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to produce a brief version of the DAS. Item response theory (IRT) can be used to gain 
understanding of the properties of the individual items, how they function relative to one 
another and particularly whether the items form a hierarchy within each subscale factor 
(Mooij, 2012). One particular form of non-parametric IRT called Mokken scaling can be used 
in scale development as a tool for the identification of unidimensional sets of items and to 
obtain additional information about the relationship between test items within such scales. 
Mokken scaling can be applied in scale design or in the development of multi-item 
questionnaires measuring health constructs (Sijtsma et al., 2008), for example scale reduction 
of the General Health Questionnaire (Watson et al. 2008) and Addenbrooke’s Cognitive 
Examination-III (Hsieh et al. 2015).  
 
The aim of this study was to apply data driven scaling methods, to derive a 9 item short form 
of the DAS, the brief DAS (b-DAS), suitable for use within research settings and the clinic. 
Previous research employing Mokken analysis has reduced scales or assessments by over 
50% (e.g. Watson et al. 2008, Hsieh et al. 2015). To ensure that each subscale was equally 
represented and that the breath of characteristics was captured for each apathy subtype, 9 
items (3 items per subscale) was chosen as the number of items for the b-DAS. Data was 
extracted from studies of ALS and AD to ensure that the new scale is appropriate for use in 
both patients with a selective and more global apathy profiles. Data was compared to a 




Participants and procedure 
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Previously collected carer data from 102 ALS patients (Radakovic et al., 2016; Radakovic et 
al., 2017b) and 102 AD patients (Radakovic et al., 2017a) was collated giving a total sample 
size of 204 and have been previously described (see Radakovic et al., 2016, Radakovic et al., 
2017a; Radakovic et al., 2017b). 
 
All participants’ carers completed the following assessments about the patients.  
The DAS (Radakovic & Abrahams, 2014) is a 24 item multidimensional apathy measure 
composed of 3 subscales- Executive, Emotional and Initiation (available through 
http://das.psy.ed.ac.uk/). The DAS was created to better profile apathy subtypes in people 
with neurodegenerative and neurological disease. Items are scored on a 4 point Likert scale 
and the scale takes approximately 5 minutes to complete. The items are summed for each 
subscale, with the total subscale score ranging from 0 (least apathetic) to 24 (most apathetic), 
with a DAS total score ranging from 0 to 72. Age and education specific cut-offs have been 
calculated for AD and ALS (Radakovic et al., 2016; Radakovic et al., 2017a). The Apathy 
Evaluation Scale (AES; Marin, Biedrzycki & Firinciogullari, 1991) is an 18 item, one-
dimensional, gold standard apathy measure. Items are scored on a 4 point Likert scale with a 
total score ranging from 18 (least apathetic) to 72 (most apathetic), with cut-offs for 
abnormality available (Marin et al., 1991; Clarke et al., 2007). Geriatric Depression Scale- 
Short form (GDS-15; Brown & Schinka, 2005), a 15 item screen used to assess patients’ 
depression. Each item was dichotomously scored (Yes/No) with the total score ranged from 0 
(least depressed) to 15 (most depressed). A cut-off of > 6 was used as an indication of 
depression (Wancata et al., 2006). 
 
Statistical Analysis 
All statistical analysis was performed using R 3.3.2, unless otherwise stated. 
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Item response analysis 
Mokken scaling analysis (Watson et al. 2012) was used to examine the hierarchy of items on 
each subscale of the informant/carer-rated Dimensional Apathy Scale (DAS) and to help 
derive the b-DAS. This method provides an indication of item difficulty and discrimination. 
Item difficulty refers to the ease with which the item is correctly responded to or endorsed. 
Item mean scores are used to represent the level of item difficulty. Discrimination refers to 
how precisely an item can differentiate between respondents with low levels of latent trait 
and those with high levels of latent trait. Discrimination also indicates the degree of 
association between items and the scale construct. With regard to scale development Mokken 
scaling analysis can be used to identify and select items with good discrimination in specific 
populations. Ideally scales would consist of items of high discrimination with different levels 
of difficulty to ensure differences and changes along the spectrum of ability or latent trait will 
be detected (Mungas & Reed, 2000). 
 
The fit of the DAS items to Mokken scaling properties was assessed by examining whether 
they conformed to the three assumptions of the monotone homogeneity model (MHM); 
unidimensionality, local stochastic independence and monotonicity. These assumptions were 
examined using a hierarchical clustering algorithm, scalability coefficients and latent 
monotonicity in the Mokken package in R (van der Ark, 2007).  
 
Automated item selection procedure (AISP). AISP is used to partition items into scales, or 
groups or related items measuring a common latent trait, using a hierarchical clustering 
algorithm. AISP is a bottom-up sequential item selection method based on the strength of 
association between the items and the latent trait. The selection procedure starts with the pair 
of items with the highest positive item-pair scalability coefficient (Hij) and continues until no 
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further items meet this criterion. Any items remaining can be selected to form a new scale in 
the same way. Items remaining out with a scale are considered unscalable (Sijtsma & 
Molenaar, 2002).  
 
Scalability coefficients. Scalability coefficients for items, item-pairs and the scale as a whole 
are calculated and used as criteria for partitioning items into scales and as measures of 
strength of the scales. The item scalability coefficient (Hi) reflects item discrimination and is 
equivalent to item-test correlation or a factor loading. Item-pair scalability coefficients (Hij) 
expresses the joint scalability of item pairs and are applied in the AISP as described above. 
The strength of the overall scale is reflected by the scalability coefficient (H). A general rule 
of thumb for interpretation of H has been described: scales with H < .30 are not considered 
unidimensional, .30  > H < .40 ‘weak’, .40 > H < .50 ‘moderate’, and H > .50 ‘strong’ 
(Mokken, 1971, Meijer & Baneke, 2004).  
 
Latent monotonicity. Monotonicity allows respondents to be ordered on the latent trait with 
respect to the summed score on the scale. Items violating this assumption can be identified 
and removed if necessary.  
 
Item-level psychometric analysis 
Item-total correlational analysis was used to examine convergent and divergent validity 
criteria of the DAS items and further stratify item selection for the brief DAS.  
 
An acceptable convergent validity criterion was determined through DAS items correlations 
with the AES total score of r > .5. An acceptable divergent validity criterion was determined 
through the DAS item correlations with GDS total score of r < .5. 
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Receiver Operating Characterise (ROC) Curve Analysis 
Receiver operating characteristic (ROC) curve analysis was performed using MedCalc for 
Windows, version 18.0 (MedCalc Software, Ostend, Belgium). Diagnosis of apathy was two 
tiered, where patients had to be classified as apathetic on both the full informant/carer-rated 
DAS subscales and the gold standard informant/carer AES only. Those that were impaired 
independently on each scale were not classified as apathetic. On this basis sensitivity, 
specificity, positive predictive value (PPV), negative predictive value (NPV) and positive 





Patient group clinical and demographic descriptors can be found in Table 1. 
 
Table 1. Demographic, apathy and depression descriptors for AD and ALS patients 
 ALS (n=102) AD (n=102) p Value Total (n=204) 
Age (Mean, SD) 63.8 (11.0) 78.2 (8.5) <.001 71.0 (12.1) 
Gender (Male/Female) 71/31 52/50 <.01 123/81 
Years of Education (Mean, SD) 13.2 (2.1) 13.2 (3.7) NS 13.2 (3.3) 
Age Onset years (Mean, SD) 59.4 (11.5) 74.6 (8.2) <.001 67.6 (12.4) 
Disease Duration months (median, 
IQR) 
48 (72) 36 (48) NS 48 (60) 
AES Total (Mean, SD) 33.2 (10.8) 51.7 (11.5) <.001 42.4 (14.4) 
GDS-15 Total (Mean, SD) 6.8 (4.7) 7.3 (4.4) NS 7.1 (4.5) 
SD = Standard Deviation; IQR = Interquartile Range; AES = Apathy Evaluation Scale; GDS-15 = 
Geriatric Depression Scale-Short form; NS = Not Significant 
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The most common informant/carer relationship for both patient groups was a spouse or 
partner. AD and ALS patients were matched for years of education, but significantly differed 
in age, gender distribution and age of onset (see Table 1). Further, AD patients were 
significantly more apathetic than ALS patients on the AES, where 75.5% of AD patient 
compared to 25.5% of ALS patients displayed apathy (based on the AES cut-offs). No such 
difference found in relation to depression, where 54.9% of AD patients and 48.0% of ALS 
patients displayed depression (based on the GDS-15 cut-offs). Correlational analysis found 
no significant relationship between the AES or GDS-15 and age or age onset, and no gender 
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Item Response Analysis, Correlational Analysis and Final Item selection 
Table 2. Executive, Emotional and Initiation subscale items ordered by discrimination (Hi). Item 








21 S/he finds it difficult to keep his/her mind on things 0.760 1.485 0.800 0.371 
17 When doing a demanding task, s/he has difficulty working 
out what s/he has to do 
0.718 1.377 0.771 0.295 
19 S/he gets easily confused when doing several things at 
once 
0.708 1.569 0.734 0.278 
10 S/he is able to focus on a task until it is finished 0.699 1.436 0.795 0.380 
1 S/he needs a bit of encouragement to get things started 0.699 1.436 0.764 0.394 
11 S/he lacks motivation 0.660 1.559 0.753 0.523 
23 S/he is easily distracted 0.649 1.544 0.625 0.338 








5 S/he is concerned about how his/her family feel 0.428 1.461 0.552 0.120 
7 Before s/he does something s/he thinks about how others 
would feel about it 
0.417 2.044 0.552 0.242 
24 S/he is indifferent to what is going on around him/her 0.402 1.103 0.699 0.355 
12 S/he struggles to empathise with other people 0.381 1.162 0.579 0.335 
9 When s/he receives bad news s/he feels bad about it 0.334 1.098 0.412 0.048 
3* S/he expresses his/her emotions 0.268 1.667 0.335 0.132 
20* S/he becomes emotional easily when watching something 
happy or sad on TV 
0.213 1.956 0.180 -0.109 
15‡ S/he is unconcerned about how others feel about his/her 
behaviour 








4 S/he thinks of new things to do during the day 0.682 2.373 0.723 0.430 
13 S/he sets goals for him/herself 0.665 2.157 0.745 0.430 
16 S/he acts on things s/he has thought about during the day 0.627 1.804 0.691 0.337 
14 S/he tries new things 0.601 2.279 0.671 0.420 
2 S/he contacts his/her friends 0.593 1.995 0.732 0.374 
8 S/he plans his/her days activities in advance 0.590 2.221 0.583 0.346 
18  S/he keeps him/herself busy 0.590 1.593 0.803 0.524 
22 S/he is spontaneous 0.501 2.034 0.503 0.362 
Hi = Item Scalability Coefficient; AES = Apathy Evaluation Scale; GDS-15 = Geriatric Depression Scale- Short Form. Difficulty is derived from mean scores 
with lower values reflecting lower item endorsement. Items in bold met Mokken Scaling Criteria and convergence-divergence validity criteria. Items in italics 
were selected for inclusion in the b-DAS. *Items partitioned in to separate scale. ‡Items failed to meet Mokken Scaling Criteria. 
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Executive. The AISP partitioned all 8 items of the Executive subscale into one scale. The 
scalability coefficients of the items were examined. All item-pair scalability coefficients (Hij) 
were non-negative and all item scalability coefficients were above 0.3. There were no 
significant violations of monotonicity. The items of the Executive subscale form a Mokken 
scale meeting MHM criteria (H=0.680, SE=0.026). See Table 2 for Executive items ordered 
by Hi.  
 
Correlational analysis in Table 2 showed that only item 11 did not meet the divergent validity 
criterion and was subsequently removed. A further examination of item scalability in 
combination with correlational analysis resulted in removal of items 6, 23, and 1. 
 
Examination of the remaining items revealed that item 19 held similarities in terms of 
confusion over management of tasks with item 17. Therefore, item 19 was removed and item 
10 utilised in its place as it examined more direct motivational elements to do with planning 
and focus to finish a tasks. This resulted in retention of items 21, 17 and 10. 
 
Emotional. The AISP partitioned five items into one scale (items 5, 7, 9, 12 and 24), two 
items into a separate scale (items 3 and 20) and determined the remaining one item (item 15) 
to be unscalable. The scalability coefficients of the five items of scale 1 were examined. 
These 5 items met the criteria for inclusion in a unidimensional Mokken MHM scale 
(H=0.501, SE=0.038). See Table 2 for Emotional items ordered by Hi.  
 
Correlational analysis in Table 2 showed that out of these items only item 9 did not meet the 
convergence validity criterion, and was subsequently removed. 
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Examination of the remaining items revealed that item 12 was similar to both items 5 and 7, 
in terms of empathy towards family or others. Therefore, item 12 was removed and item 24 
was utilised in its place, as it explicitly examined indifference, an important facet of 
Emotional apathy. This resulted in retention of items 5, 7 and 24. 
 
Initiation. All items were partitioned into one scale through the AISP. Scalability coefficients 
all met the required criterion for inclusion in a Mokken scale with non-negative item-pair 
scalability coefficients, item scalability coefficients greater than .30 for all items and a scale 
H of 0.615 (SE=0.031). There were no violations of monotonicity. See Table 2 for Initiation 
items ordered by Hi. 
 
Correlational analysis in Table 2 showed that only item 18 did not meet the divergent validity 
criterion and was subsequently removed. A further examination of item scalability in 
combination with correlational analysis resulted in removal of items 22, 8 and 2. 
 
Examination of the remaining items revealed that item 14 was similar to item 4, in relation to 
motivation for new things. Therefore, item 14 was removed and item 16 was utilised in its 
place, as it assesses the ability to act on things they have already thought about. This resulted 
in retention of items 4, 13 and 16. 
 
This resulted in the b-DAS composed of 9 items, equally distributed over Executive, 
Emotional and Initiation apathy subscales. For each item a supplementary awareness deficit 
question was added (“Are they aware of this specific difficulty?”), which is answered 
dichotomously (Yes/No) when the item is scored on the upper two points of the Likert Scale. 
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Summation of the awareness deficit questions responses (“Yes”) for each apathy subtype can 
be 0 = Intact Awareness, 1 = Mild Awareness Deficit, 2 = Moderate Awareness Deficit and 3 
= Severe Awareness Deficit. 
 
ROC Curve analysis of b-DAS 
Table 3. Sensitivity, Specificity, positive and negative predictive values and positive likelihood 





Sensitivity Specificity PPV (NPV) +LR 
Executive 3 100.0 74.6 72.6 (100.0) 3.94 
 4 98.8 86.9 83.5 (99.1) 7.53 
 5 93.9 97.5 96.2 (96.0) 38.19 
 6 78.1 99.2 98.5 (87.1) 95.22 
      
Emotional 4 98.2 66.7 51.5 (99.0) 2.94 
 5 94.4 77.3 60.0 (97.5) 4.17 
 6 87.0 94.0 83.9 (95.3) 14.51 
 7 55.6 98.0 90.9 (86.0) 27.78 
      
Initiation 5 100.0 68.5 73.8 (100.0) 3.18 
 6 96.9 84.3 84.5 (96.8) 6.15 
 7 82.3 92.6 90.8 (85.5) 11.11 
 8 55.2 97.2 94.6 (70.9) 19.87 
PPV = Positive Predictive Value; NPV = Negative Predictive Value; +LK = Positive Likelihood 
Ratio. Criteria in bold were considered optimal either in terms of sensitivity or specificity. 
 
Table 3 shows results of sensitivity, specificity, PPV, NPV and +LR for each cut-off for each 
b-DAS subscale. For the Executive apathy a cut-off of 4 was found to be optimal for 
sensitivity and a cut-off 5 was optimal for specificity, both with high predictive values (PPV 
and NPV). Therefore the recommended cut-off for this b-DAS subscale was determined as > 
4. For Emotional apathy a cut-off of 5 was found to be optimal for sensitivity and a cut-off 6 
Brief Dimensional Apathy Scale (b-DAS) 
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was optimal for specificity, with the latter having a lower PPV than the former, but 
comparable NPV. The recommended cut-off for this b-DAS subscale was determined as > 5. 
Finally, for Initiation apathy a cut-off of 6 was found to be optimal for sensitivity and a cut-
off 7 was optimal for specificity, with comparable PPV and NPV. The recommended cut-off 
for this b-DAS subscale was determined as > 6. The selected cut-offs have high sensitivity 
and specificity with likelihood ratios indicating that scores on or above these cut-offs are 
more than 4 times likely to be from a patient with apathy than without. 
 
Discussion 
We present the b-DAS, an informant/carer-based, 9-item multidimensional apathy instrument 
to measure Executive, Emotional and Initiation apathy subtypes, in addition to 
insight/awareness deficit, of people living with neurological disease. The inclusion of the 
Awareness (or Insight) deficit measure ensures that self-knowledge relating motivational 
problems can be quantified for each subtype, which may have particular relevance for clinical 
intervention and management of this symptom. Each subscale has a minimum score of 0 
(least apathy) maximum score of 9 (most apathy), with clinical cut-offs for Executive > 4, 
Emotional > 5 and Initiation > 6 apathy subscales, taking in to account sensitivity and 
specificity as well as NPV and PPV. This is further supplemented by Awareness deficit 
classification for each subtype ranging from 0 as “Intact” to 3 as “Severe”. This reflects the 
importance of awareness of demotivation in diseases such as AD or other dementias 
(Radakovic & Abrahams, 2018). In comparison with the original DAS, the b-DAS takes less 
than 5 minutes to complete, increasing the efficiency of assessment (the DAS and b-DAS are 
available through http://das.psy.ed.ac.uk/ or by contacting the lead author).  
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The Mokken Scaling IRT analysis of the DAS showed that most item scalability coefficients 
were above the recommended threshold level for inclusion in a Mokken scale for creation of 
the b-DAS, indicating adequate sample size (Straat et al. 2014). There was an exception in 
relation to the Emotional apathy subscale, where some items were below the scalability 
coefficient threshold of 0.3 and were partitioned in to different scales. Previous research 
using the DAS has suggested that the Emotional apathy may be composed of subdomains of 
“Individual” Emotional apathy relating to personal and internal emotional motivation (or 
“inertia”) and “Social” Emotional apathy relating to motivation towards external and 
complex interactions (M’Barek et al., In Press). The b-DAS includes items from both these 
possible Emotional apathy subdomains, however research is needed to explore their 
reliability and consistency. Further, inclusion of both the AD and ALS patient groups gave a 
large enough sample size (n=204) to allow for a robust Mokken scaling analysis to be 
performed. A simulation study investigating adequate sample sizes for Mokken scaling 
determined that the strength of item scalability coefficients, Hi, is inversely proportional to 
sample size which serves as a good indicator of adequate sample size (Straat, 2012). Further, 
while there are other parametric IRT methods available (e.g. Rasch analysis and the two-
parameter model extension), our use of the non-parametric Mokken analysis was driven by 
the less stringent assumptions of this method in relation to the item responses (Van Schuur, 
2003). This was considered favourable when working with a patient population as responses 
on items are inherently heterogeneous. Additionally, as the profiles of apathy are different in 
ALS and AD, this covers the breadth of demotivational characteristics within disease. 
 
Further, the inclusion of convergence and divergence criteria against gold-standard apathy 
and depression measures ensured that items selected for the b-DAS were of a high validity. 
While there is a degree of overlap between one-dimensional apathy and depression (Landes 
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et al., 2001; Tagariello et al., 2009), an emerging consensus is that in terms of subtypes, 
Executive and Initiation apathy may be associated to a degree with depression, whereas 
Emotional apathy diverges in terms of emotional neutrality (Radakovic et al., 2016; 
Radakovic et al., 2017a; Radakovic et al., 2018). This points towards the importance and 
necessity of further research to specifically elucidate the relationship of apathy subtypes and 
depression. 
 
The b-DAS subscale cut-offs that were selected balanced highest sensitivity and specificity, 
to maximise identification of apathy subtypes. The cut-offs that are recommended marginally 
favoured sensitivity over specificity, as overlooking apathetic deficits may have more 
negative effects than false detection, in terms for example activities of daily living, carer 
distress or burden, quality of life and survival (e.g. Starkstein et al., 2006; Kamiya et al., 
2014; Watermeyer et al., 2015; Caga et al, 2016). 
 
Furthermore, an awareness deficit assessment has been added to the b-DAS, which was 
driven by its importance as emerging concept of demotivation-based self-awareness 
(Radakovic & Abrahams, 2018). The apathy subtype profile in AD seems to be characterised 
by this awareness deficit (Radakovic et al., 2017a), when compared to ALS and Parkinson’s 
disease (Radakovic et al., 2016; Santangelo et al., 2017a; Santangelo et al., 2017b; Radakovic 
et al., 2018). The awareness deficit assessment within the b-DAS predominantly examines 
self-knowledge of specific impairments associated with apathy (Marková & Berrios, 2011). 
However, there are also elements of the wider concept of insight that are assessed (Marková 
& Berrios, 2011), in that there is a quantitative and qualitative appraisal by the 
informant/carer of the patient’s awareness of this specific “difficulty” (i.e. highly endorsed b-
DAS item). Additionally, Starkstein (2014) found that anosognosia (or loss of 
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insight/awareness) is associated with apathy and might be implicit in lower adherence to 
pharmacological and non-pharmacological treatment. Assessment of the insight/awareness 
deficit in the b-DAS therefore increases the practical applicability of this measure in clinic, 
but would need to be further explored to determine specific the distribution of different 
apathy awareness deficits as well as clinical cut-offs.  
 
In conclusion, the b-DAS is a comprehensively designed, short, informant/carer-rated tool 
that assesses different subtypes of apathy and associated awareness deficits that can be used 
quickly in clinic and research. We present recommended cut-offs for each b-DAS subscale 
that can be applied to neurodegenerative, as well as other neurological, conditions. Future 
clinical practice and research should utilise the b-DAS to explore its clinical applicability, so 
as to determine how demotivation impacts clinical decision making, treatment choice or 
adherence, quality of life of patients and carer burden. This will help guide and design 
interventions or strategies to manage syndromic apathy. 
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